Stantec (STN) Q4 2025 earnings review
Record Margins and Strong Cash Flow Eclipse Sluggish U.S. Organic Growth
Stantec closed out a record 2025 by hitting its 2024-2026 strategic Adjusted EBITDA margin target (17.6%) a full year ahead of schedule. Total net revenue grew 10.9% YoY in Q4 to $1.64B, heavily aided by the Page acquisition. However, beneath the impressive consolidated numbers, a stark divergence is emerging: the Global and Canada segments are firing on all cylinders, while the U.S. organic engine has stalled, registering just 2.1% revenue growth in Q4 and a meager 0.2% organic backlog growth for the year. Despite this, management remains highly confident, hiking the dividend by 8.9% and issuing robust 2026 guidance that projects 15-18% Adjusted EPS growth.
🐂 Bull Case
Stantec delivered an impressive 17.6% Adjusted EBITDA margin for FY25, expanding 90 bps YoY and achieving its 2026 strategic target a year early. Guidance suggests further expansion to 17.6-18.2% in 2026.
Operating cash flow surged 43% in 2025 to $862.9M, driven by excellent working capital management (DSO improved by 8 days to 69). Net debt-to-Adjusted EBITDA sits at a comfortable 1.3x, leaving ample dry powder for future M&A.
🐻 Bear Case
The U.S. segment—Stantec's largest—saw organic backlog growth of just 0.2% for the year, and Q4 organic revenue growth decelerated to 2.1%. This raises serious questions about management's guidance for mid-to-high single-digit U.S. organic growth in 2026.
While adjusted metrics shine, actual Q4 Net Income dropped 4.2% YoY to $93.9M, and diluted EPS fell 4.7%. This was primarily driven by the heavy amortization of intangible assets stemming from the Page and Ryan Hanley acquisitions.
⚖️ Verdict: 🟢
Bullish. While the lack of U.S. organic momentum is a valid concern, Stantec's operational discipline is exceptional. Their ability to aggressively expand margins, generate massive cash flow, and successfully integrate large acquisitions makes them highly resilient even if one geography lags.
Key Themes
Global Water Segment Fueling Backlog
The Global segment continues to be a powerhouse, reporting 14.2% organic backlog growth for the year. This is heavily driven by secular tailwinds in the Water business, particularly the ongoing Asset Management Program (AMP8) in the UK. Stantec's strategic positioning in international water infrastructure provides highly visible, multi-year recurring revenue.
U.S. Procurement Delays Cementing into a Trend
Management had previously classified U.S. federal and public sector procurement delays as 'transitory.' However, the Q4 data tells a decelerating story: U.S. organic revenue growth dropped to 2.1% (down from 4.6% in Q3 and 10.3% a year ago). The flat U.S. organic backlog (+0.2% YoY) strongly suggests that these delays are structural headwinds entering 2026, contradicting the company's optimistic U.S. guidance.
Unrelenting Margin Expansion Strategy
Stantec's margin story is accelerating. FY25 Adjusted EBITDA margin hit 17.6% (up 90 bps), and Q4 hit 17.3% (up 60 bps). This wasn't driven by project margin expansion (which actually compressed slightly), but by ruthless discipline in administrative and marketing expenses. Expanding high-value delivery centers (like Pune, India) and optimizing digital strategies have structurally permanently lowered their operating costs.
GAAP vs. Non-GAAP Divergence on M&A
The bill for Stantec's aggressive M&A strategy (notably Page) is arriving via the amortization line. In Q4, amortization of intangible assets surged 112% to $51.7M. This caused GAAP Net Income to reverse into negative growth (-4.2% YoY), while Adjusted Net Income grew 13.2%. Investors should monitor this divergence, as 'adjusted' metrics are increasingly ignoring the real capital costs of their acquisition strategy.
Real Estate Optimization Yielding Results
Stantec exceeded its real estate footprint reduction targets, shrinking its physical footprint by 11% relative to a 2023 baseline. This drove approximately $0.17 of incremental Adjusted EPS savings in 2025 and significantly lowered non-cash impairment charges ($6.0M in 2025 vs. $34.9M in 2024).
Other KPIs
Accelerating improvement. DSO dropped an impressive 8 days YoY, far surpassing the company's internal target of 80 days. This excellence in collections directly fueled the 43% spike in operating cash flow.
Stable but slightly decelerating. Q4 project margins compressed by 50 basis points from 55.0% in 24Q4. Management attributed this to lower project recoveries and change order approvals compared to an unusually strong comparative quarter.
Accelerating. The company comfortably beat its 1.0x target, proving that its net income quality (from a cash conversion standpoint) remains exceptionally high, supporting the 8.9% dividend increase.
Guidance
Stable. The midpoint of 10.0% is roughly in line with the 10.7% achieved in FY25. Management expects this to be driven by mid-to-high single-digit organic growth across all regions. Achievement highly depends on the U.S. segment rebounding from its current flat organic backlog trajectory.
Accelerating. Management expects to build on FY25's record 17.6% margin, citing further scale efficiencies and high-value center utilization. Expect margins to be near the low end in Q1/Q4 and above the high end in Q2/Q3 due to Northern Hemisphere seasonality.
Decelerating slightly compared to the robust 19.9% growth printed in FY25, but still represents exceptional bottom-line momentum. This guidance excludes any future unannounced M&A activity.
Stable. The company ended FY25 at 1.3x and is maintaining its target range, indicating it remains fully primed to execute further acquisitions without over-leveraging.
Key Questions
U.S. Organic Backlog Disconnect
U.S. organic backlog growth was essentially flat for the year at 0.2%. Given this lack of pipeline expansion, what specific leading indicators give you the confidence to guide for mid-to-high single-digit U.S. organic revenue growth in 2026?
Project Margin Compression
We saw a 50 basis point compression in Q4 project margins. With administrative cost leverage potentially nearing an optimal floor, what are the primary levers to ensure project margins expand, or at least stabilize, to hit the 18% EBITDA margin ceiling in 2026?
M&A Pipeline vs. Internal Integration
With the heavy amortization drag from the Page and Ryan Hanley deals now visible in GAAP earnings, are you prioritizing the integration of these massive assets in 2026, or does the 1.3x leverage ratio mean you are actively hunting for another transformational deal?